Health Canada approved on Thursday the use of the Pfizer-BioNTech COVID-19 booster vaccine that targets the BA.4 and BA.5 strains of the Omicron variant. It is the second combination vaccine greenlighted by Health Canada's vaccine review team, but the first that targets the virus strains that are now most common in Canada
